![[American Thoracic Society American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans - ()] B16. PULMONARY ARTERIAL HYPERTENSION: FROM ASSESSING RISK TO THERAPEUTIC RESULTS - Effects Of Inhaled Aviptadil (Vasoactive Intestinal Peptide) In Patients With Pulmonary Arterial Hypertension (PAH)]()
[American Thoracic Society American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans - ()] B16. PULMONARY ARTERIAL HYPERTENSION: FROM ASSESSING RISK TO THERAPEUTIC RESULTS - Effects Of Inhaled Aviptadil (Vasoactive Intestinal Peptide) In Patients With Pulmonary Arterial Hypertension (PAH)Galie, Nazzareno; Boonstra, Anco; Ewert, Ralf; Gomez-Sanchez, Miguel A.; Barbera, Joan A.; Torbicki, Adam; Bremer, Hinrich; Ghofrani, Ardeschir; Naeije, Robert; Gruenig, Ekkehard; Leuchte, Hanno; Simonneau, Gérald; Klose, Hans; Peacock, Andrew; Wilkens, Heinrike; Bevec, Dorian; Cavalli, Vera; Bacher, Gerald; Rubin, Lewis J. · 2010